The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
SIN-1 resulted in an 8.6 fold increase in SN compared to CI-1044 alone, and a 4.6<br />
fold increase from SIN-1 alone. Mesenteric and periarterial inflammation in the<br />
CI-1044 group was increased compared to vehicle controls, L-NAME or SIN-1<br />
groups. Mild arterial fibrinoid necrosis was also present in a subset <strong>of</strong> animals<br />
treated with CI-1044. Co-administration <strong>of</strong> CI-1044 and L-NAME resulted in reduced<br />
mesenteric and periarterial inflammation compared to CI-1044 alone.<br />
Furthermore, arterial medial injury was not noted. Co-administration <strong>of</strong> CI-1044<br />
and SIN-1 resulted in a marked increase in mesenteric arterial injury and inflammation<br />
compared to SIN-1 or CI-1044 alone. <strong>The</strong> present study suggests a link between<br />
NO modulation and DIVI. Future studies will be aimed at further defining<br />
the pathogenesis <strong>of</strong> this unique type <strong>of</strong> injury.<br />
1745 INVOLVEMENT OF SHEAR STRESS IN FENOLDOPAM<br />
AND DOPAMINE INDUCED MESENTERIC MEDIAL<br />
ARTERIAL NECROSIS.<br />
D. Dalmas, M. Scicchitano, K. Roland, D. Mullins, T. Chordia, K. Frazier and<br />
H. Thomas. Safety Assessment, GlaxoSmithKline, King <strong>of</strong> Prussia, PA.<br />
Extrapolation and relevance <strong>of</strong> drug-induced rodent vascular injury to humans has<br />
hampered drug development due to lack <strong>of</strong> understanding <strong>of</strong> the pathologic mechanisms<br />
involved. Although vasodilatation & increased shear stress (SS) have been<br />
hypothesized to be involved in the pathogenesis <strong>of</strong> these lesions, the exact role <strong>of</strong> SS<br />
on primary target cells, smooth muscle (SMC) and endothelial cells (EC) in vivo<br />
remain unclear. Dopaminergic DA1 agonists such as Fenoldopam and Dopamine<br />
reproducibly induce mesenteric medial arterial necrosis (MAN) in rats following<br />
single vasotoxic doses. To investigate the involvement <strong>of</strong> SS in the development <strong>of</strong><br />
MAN, rats were given vehicle, Dopamine or Fenoldopam for 4 days followed by<br />
necropsy 24 hours later. Yohimbine, an α2 adrenoreceptor antagonist, also vasoactive<br />
but lacking MAN histologic lesions, was given to rats for 4 days for comparison.<br />
To evaluate the timecourse <strong>of</strong> lesion development, rats were also given vehicle<br />
or a single vasotoxic dose <strong>of</strong> Fenoldopam and necropsied 1-, 4-, 6-, 12- or 24 hours<br />
postdose. Mesentery from each rat was collected and frozen in OCT, then EC and<br />
SMC were microdissected from sections <strong>of</strong> mesenteric arteries <strong>of</strong> each rat, and<br />
RNA was amplified and analyzed. Regulation <strong>of</strong> 37 shear stress responsive genes<br />
were evaluated using TaqMan gene expression pr<strong>of</strong>iling. Many <strong>of</strong> the genes evaluated<br />
were confirmed to be differentially expressed by Dopamine and Fenoldopam<br />
in EC- and/or SMC-enriched samples as compared to controls or Yohimbine following<br />
4 daily doses. A number <strong>of</strong> SS responsive genes were also shown to be differentially<br />
regulated beginning 1- and/or 4-hours post-Fenoldopam treatment and<br />
prior to histological evidence <strong>of</strong> MAN (which was initially observed beginning at<br />
12-hours). Evaluation <strong>of</strong> this panel <strong>of</strong> genes has provided evidence <strong>of</strong> the involvement<br />
and regulation <strong>of</strong> SS responsive genes in both EC and SMC during the development<br />
<strong>of</strong> Dopamine and Fenoldopam-induced vascular injury.<br />
every timepoint analyzed except recovery animals. EMPs with phenotypes <strong>of</strong><br />
CD45-CD42d-CD31+CD54+, CD45-CD42d-CD31+CD146+, CD45-CD42d-<br />
CD54+CD146+ and CD45-CD42d-CD106+Flk-1+ were increased significantly<br />
24 hours after drug treatment and correlated with histopathology data. EMP levels<br />
dropped to baseline levels after 10 days <strong>of</strong> recovery. <strong>The</strong> present study suggests that<br />
EMPs potentially represent a novel biomarker for DIVI observed in preclinical<br />
species.<br />
1747 A NOVEL MECHANISM FOR ALCOHOLIC<br />
CARDIOMYOPATHY: SUPEROXIDE GENERATION IS A<br />
PIVOTAL MEDIATOR FOR SUPPRESSION OF GAPDH<br />
THAT TRIGGERS CARDIAC IMBALANCE OF ENERGY<br />
UTILIZATION, OXIDATIVE STRESS, AND<br />
REMODELING.<br />
Y. Tan 1 , Z. Zhou 2 and L. Cai 1 . 1 Pediatrics, University <strong>of</strong> Louisville, Louisville, KY<br />
and 2 Medicine, University <strong>of</strong> Louisville, Louisville, KY.<br />
We tried to define whether ethanol may induce NADPH oxidase-dependent superoxide<br />
that inhibits GAPDH, thereby diverting upstream metabolites from glycolysis<br />
into pathways <strong>of</strong> glucose overutilization, resulting in an imbalance <strong>of</strong> glucose<br />
and fatty acid utilization, cardiac oxidative stress and structural remodeling. Male<br />
C57/BL6 mice were pair-fed an alcohol or isocaloric maltose dextrin liquid diet for<br />
two months. Chronic alcohol feeding caused a significant increase in NADPH oxidase<br />
expression and a decrease in GAPDH expression, and also caused a cardiac<br />
glucose overutilization, shown by increased GSK-3β phosphorylation and hexokinase<br />
II expression, and fatty acid metabolism disorder, evidenced by increased<br />
PPARα (a positive mediator for fatty acid uptake and utilization) and decreased<br />
PGC-1α (an essential regulator for the optimal cardiac mitochondrial fatty acid oxidation).<br />
<strong>The</strong> imbalanced energy utilization was associated with significant increases<br />
in cardiac oxidative damage, shown by 3-nitrotyrosine accumulation, cell<br />
death and neutrophil infiltration, and cardiac remodeling, mirrored by cardiac hypertrophy<br />
and fibrosis (TGF-β1 and CTGF expression). To define the critical role<br />
<strong>of</strong> superoxide, cardiac H9c2 cells were treated with 2.5% (v/v) ethanol for 120<br />
hours, which induced significant oxidative damage, cell death, and fibrosis, as observed<br />
in the hearts <strong>of</strong> alcoholic mice. However, pre-incubation <strong>of</strong> cells with superoxide<br />
dismutase mimetic significantly attenuated ethanol-decreased GAPDH expression,<br />
along with improvement <strong>of</strong> the above described pathogenic changes.<br />
<strong>The</strong>refore, alcohol activation <strong>of</strong> NADPH oxidase-related superoxide generation<br />
plays a critical role in depressing GADPH expression. <strong>The</strong> decreased expression and<br />
function <strong>of</strong> GAPDH may be the key mediator leading to cardiac imbalance <strong>of</strong> glucose<br />
and fatty acid utilization, oxidative damage, inflammation and remodeling<br />
that eventually results in alcoholic cardiomyopathy.<br />
1746 IDENTIFICATION AND ANALYSIS OF CIRCULATING<br />
ENDOTHELIAL MICROPARTICLES AS A POTENTIAL<br />
BIOMARKER OF DRUG-INDUCED VASCULAR INJURY.<br />
B. Enerson, C. Conley, C. Huang, M. Kate and S. Sokolowski. Drug Safety<br />
Research and Development, Pfizer Global Research and Development, Groton, CT.<br />
Sponsor: M. Lawton.<br />
<strong>The</strong> finding <strong>of</strong> acute drug-induced vascular injury (DIVI) in preclinical toxicity<br />
studies <strong>of</strong>ten leads to delays in, or termination <strong>of</strong>, drug development projects because<br />
the relevance <strong>of</strong> this finding to humans is unclear. Furthermore, there are no<br />
sensitive and specific DIVI biomarkers that readily translate into a clinical setting.<br />
Endothelial microparticles (EMPs) are small vesicles that are released from endothelial<br />
cells into circulating blood and are found at elevated levels in a number <strong>of</strong><br />
human diseases associated with vascular or endothelial dysfunction. <strong>The</strong> purpose <strong>of</strong><br />
this study was to identify and quantify by flow cytometry circulating EMPs in<br />
plasma <strong>of</strong> rats treated with phosphodiesterase 4 (PDE4) inhibitor CI-1044. In this<br />
time-course study, platelet-poor plasma (PPP) was collected from male Sprague<br />
Dawley rats (5/time point) 4, 8, 16, and 24 hours following a single dose, 24 hours<br />
following either 2 or 3 daily doses, and 10-days following 3 daily doses <strong>of</strong> 80<br />
mg/kg/day CI-1044. Detection <strong>of</strong> EMPs in PPP was accomplished using markers<br />
specific for endothelial cells (CD31, CD106, CD146, CD54, Flk-1, vWF).<br />
Additional exclusion markers (CD45 and CD42d) and the apoptotic marker<br />
Annexin V were included to further characterize the origin <strong>of</strong> microparticles. All<br />
stained PPP samples were processed concurrently with microbeads to set a baseline<br />
for size and EMPs were identified based on size and labeling with specific markers.<br />
Administration <strong>of</strong> CI-1044 to rats resulted in increased plasma levels <strong>of</strong> EMPs at<br />
1748 POLYCHLORINATED BIPHENYL INDUCED VCAM-1<br />
EXPRESSION IS ABOLISHED IN AORTIC<br />
ENDOTHELIAL CELLS ISOLATED FROM CAVEOLIN-1<br />
DEFICIENT MICE.<br />
S. Han 1 , M. Toborek 2 and B. Hennig 1 . 1 Animal and Food Sciences, University <strong>of</strong><br />
Kentucky, Lexington, KY and 2 Department <strong>of</strong> Neurosurgery, University <strong>of</strong> Kentucky,<br />
Lexington, KY.<br />
Environmental chemical contaminants, such as polychlorinated biphenyls (PCBs)<br />
are known to be atherogenic in human and the underlying mechanism is becoming<br />
elucidated. Vascular cell adhesion molecule-1 (VCAM-1) is a critical mediator for<br />
adhesion and uptake <strong>of</strong> monocytes in the initial stage <strong>of</strong> atherosclerosis development<br />
in endothelium. PCBs may be proatherogenic by causing upregulation <strong>of</strong><br />
VCAM-1. Caveolae are particularly abundant in endothelial cell membrane and are<br />
involved in trafficking and signal transduction. <strong>The</strong> objective <strong>of</strong> this study was to<br />
investigate the role <strong>of</strong> caveolae in PCB-induced endothelial cell dysfunction.<br />
Primary mouse aortic endothelial cells (MAECs) isolated from caveolin-1 deficient<br />
mice and background C57BL/6 mice were treated with coplanar PCBs, such as<br />
PCB77 and PCB126. In addition, siRNA gene silencing technique was used to<br />
knockdown caveolin-1 in porcine vascular endothelial cells. Expression <strong>of</strong> VCAM-<br />
1 was observed as a proatherogenic marker in cells. Both coplanar PCBs increased<br />
mRNA and protein levels <strong>of</strong> VCAM-1 and number <strong>of</strong> adhered monocytes in<br />
porcine endothelial cells. In MAECs, VCAM-1 mRNA and protein levels were increased<br />
after exposure to both coplanar PCBs in cells with caveolin-1, whereas not<br />
significantly altered in cells absent caveolin-1. Furthermore, number <strong>of</strong> adhered<br />
monocyte was significantly increased by PCB exposure only in caveolin-1 containing<br />
MAECs. Similarly, caveolin-1 silencing using siRNA technique in porcine en-<br />
372 SOT 2010 ANNUAL MEETING